FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972670259> ?p ?o ?g. }

• W1972670259 endingPage "518" @default.
• W1972670259 startingPage "508" @default.
• W1972670259 abstract "One hundred ten critically ill patients with acute renal failure receiving acute continuous hemodiafiltration (ACHD) in our intensive care unit were studied prospectively. Acute continuous hemodiatiltration consisted either of continuous arteriovenous hemodiafiltration or of continuous veno-venous hemodiafiltration, and was used for 17,817 hours (mean duration of patient treatment, 161.9 hours), resulting in a fall from a mean pre-ACHD urea of 35.7 mmol/L to a plateau value of 16.8 mmol/L at 72 hours of treatment. The mean urea clearance achieved was 24.9 mL/min. Eighty of these patients (72.7%) were receiving artificial ventilation at the time of ACHD and 45 (40.9%) had more than four failing organs. The mean APACHE II score was 27.7. Despite the degree of illness severity, 42 patients (32.2%) survived to discharge from hospital. The use of ACHD was associated with hemodynamic stability, rapid normalization of electrolytes, and the ability to freely administer drugs, blood, and/or blood products. It also allowed for maintenance of an aggressive, nitrogen-rich, nutritional regimen. Support of these critically ill patients with acute renal failure using ACHD was achieved safely and without the employment of additional dialysis-trained nursing staff. Our own experience and a review of the available literature strongly suggest that the advantages associated with the use of ACHD therapies are clinically significant and support the view that ACHD is a modality of renal replacement most suited to critically ill patients with acute renal failure. One hundred ten critically ill patients with acute renal failure receiving acute continuous hemodiafiltration (ACHD) in our intensive care unit were studied prospectively. Acute continuous hemodiatiltration consisted either of continuous arteriovenous hemodiafiltration or of continuous veno-venous hemodiafiltration, and was used for 17,817 hours (mean duration of patient treatment, 161.9 hours), resulting in a fall from a mean pre-ACHD urea of 35.7 mmol/L to a plateau value of 16.8 mmol/L at 72 hours of treatment. The mean urea clearance achieved was 24.9 mL/min. Eighty of these patients (72.7%) were receiving artificial ventilation at the time of ACHD and 45 (40.9%) had more than four failing organs. The mean APACHE II score was 27.7. Despite the degree of illness severity, 42 patients (32.2%) survived to discharge from hospital. The use of ACHD was associated with hemodynamic stability, rapid normalization of electrolytes, and the ability to freely administer drugs, blood, and/or blood products. It also allowed for maintenance of an aggressive, nitrogen-rich, nutritional regimen. Support of these critically ill patients with acute renal failure using ACHD was achieved safely and without the employment of additional dialysis-trained nursing staff. Our own experience and a review of the available literature strongly suggest that the advantages associated with the use of ACHD therapies are clinically significant and support the view that ACHD is a modality of renal replacement most suited to critically ill patients with acute renal failure." @default.
• W1972670259 created "2016-06-24" @default.
• W1972670259 creator A5011216396 @default.
• W1972670259 creator A5081664478 @default.
• W1972670259 date "1993-05-01" @default.
• W1972670259 modified "2023-10-15" @default.
• W1972670259 title "Acute Continuous Hemodiafiltration: A Prospective Study of 110 Patients and a Review of the Literature" @default.
• W1972670259 cites W1965887484 @default.
• W1972670259 cites W1970255707 @default.
• W1972670259 cites W1972549039 @default.
• W1972670259 cites W1973590732 @default.
• W1972670259 cites W1976643459 @default.
• W1972670259 cites W1984179354 @default.
• W1972670259 cites W1990491813 @default.
• W1972670259 cites W1991548285 @default.
• W1972670259 cites W2000296845 @default.
• W1972670259 cites W2000879677 @default.
• W1972670259 cites W2001730726 @default.
• W1972670259 cites W2004119378 @default.
• W1972670259 cites W2005652653 @default.
• W1972670259 cites W2011291552 @default.
• W1972670259 cites W2012910824 @default.
• W1972670259 cites W2014725795 @default.
• W1972670259 cites W2019076988 @default.
• W1972670259 cites W2021095114 @default.
• W1972670259 cites W2021375989 @default.
• W1972670259 cites W2021564447 @default.
• W1972670259 cites W2023319912 @default.
• W1972670259 cites W2025472417 @default.
• W1972670259 cites W2030802697 @default.
• W1972670259 cites W2032263561 @default.
• W1972670259 cites W2039341109 @default.
• W1972670259 cites W2040759300 @default.
• W1972670259 cites W2041812208 @default.
• W1972670259 cites W2041870951 @default.
• W1972670259 cites W2042486217 @default.
• W1972670259 cites W2044704446 @default.
• W1972670259 cites W2045658905 @default.
• W1972670259 cites W2045683603 @default.
• W1972670259 cites W2048749215 @default.
• W1972670259 cites W2052250406 @default.
• W1972670259 cites W2052661527 @default.
• W1972670259 cites W2067953735 @default.
• W1972670259 cites W2069564587 @default.
• W1972670259 cites W2078736871 @default.
• W1972670259 cites W2079232151 @default.
• W1972670259 cites W2079565472 @default.
• W1972670259 cites W2084562515 @default.
• W1972670259 cites W2092378937 @default.
• W1972670259 cites W2093703504 @default.
• W1972670259 cites W2094014737 @default.
• W1972670259 cites W2107907376 @default.
• W1972670259 cites W2114901064 @default.
• W1972670259 cites W2132789352 @default.
• W1972670259 cites W2201131862 @default.
• W1972670259 cites W2227274816 @default.
• W1972670259 cites W2240183199 @default.
• W1972670259 cites W2260655485 @default.
• W1972670259 cites W2265330742 @default.
• W1972670259 cites W2267061240 @default.
• W1972670259 cites W2270721561 @default.
• W1972670259 cites W2287705420 @default.
• W1972670259 cites W2289969596 @default.
• W1972670259 cites W2290978722 @default.
• W1972670259 cites W2306699339 @default.
• W1972670259 cites W2318794714 @default.
• W1972670259 cites W2339205818 @default.
• W1972670259 cites W2399872744 @default.
• W1972670259 cites W2417834464 @default.
• W1972670259 cites W342025609 @default.
• W1972670259 cites W4293242440 @default.
• W1972670259 cites W51673488 @default.
• W1972670259 doi "https://doi.org/10.1016/s0272-6386(12)80397-0" @default.
• W1972670259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8488819" @default.
• W1972670259 hasPublicationYear "1993" @default.
• W1972670259 type Work @default.
• W1972670259 sameAs 1972670259 @default.
• W1972670259 citedByCount "59" @default.
• W1972670259 countsByYear W19726702592013 @default.
• W1972670259 countsByYear W19726702592015 @default.
• W1972670259 countsByYear W19726702592019 @default.
• W1972670259 countsByYear W19726702592020 @default.
• W1972670259 crossrefType "journal-article" @default.
• W1972670259 hasAuthorship W1972670259A5011216396 @default.
• W1972670259 hasAuthorship W1972670259A5081664478 @default.
• W1972670259 hasConcept C126322002 @default.
• W1972670259 hasConcept C141071460 @default.
• W1972670259 hasConcept C159641895 @default.
• W1972670259 hasConcept C177713679 @default.
• W1972670259 hasConcept C188816634 @default.
• W1972670259 hasConcept C2776376669 @default.
• W1972670259 hasConcept C2777080012 @default.
• W1972670259 hasConcept C2778063415 @default.
• W1972670259 hasConcept C2778176769 @default.
• W1972670259 hasConcept C2778865887 @default.
• W1972670259 hasConcept C2779541074 @default.
• W1972670259 hasConcept C2779978075 @default.
• W1972670259 hasConcept C2780472472 @default.

• next